The World Health Organization has prequalified a tool for the quick diagnosis of hepatitis C. Since treatment for hepatitis C has become affordable and available in low and middle-income countries, the organization believes that the prequalification of an effective diagnostic tool will improve the number of patients cured.
hepatitis C
Breaking News
New hepatitis C drugs that shorten treatment times are largely cost-effective despite their hefty U.S. price tags, according to two new analyses.
France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.
Subscribe to VCpost newsletter
Most Popular
- Walgreens to Open a New Pharmacy Offering Cell and Gene Therapies to Patients With Chronic Diseases Like Cancer
- Walmart Founder's Son Rob Walton to Step Down From Board
- SSI Payment for May 2024: Supplemental Security Income Recipients to See Double Amount in Payout
- How to Apply for Social Security Spousal Benefits; Here's How You May Boost Your Money!
- Doctors Raise Concerns Over Proposed Capital Gains Tax Changes
- How to Get IRS Unclaimed Tax Refunds: Here's What to Do If You Think You Have Pending Payments
- US Secretary of State Antony Blinken Calls on China to Treat American Companies Fairly During Visit to Shanghai
- Kroger and Albertsons to Sell off 166 Stores in Effort to Gain Approval for Their $25 Billion Merger
